A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149) (Q33732398)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149) |
scientific article |
Statements
1 reference
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149) (English)
1 reference
Lode J Swinnen
1 reference
Cathryn Rankin
1 reference
Hetty Carraway
1 reference
Kathy S Albain
1 reference
Jeannette J Townsend
1 reference
George Thomas Budd
1 reference
Julie A Kish
1 reference
Saul E Rivkin
1 reference
Deborah T Blumenthal
1 reference
16 November 2007
1 reference
1 reference
86
1 reference
353-358
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference